[go: up one dir, main page]

GB2003887A - Isolation of peptides from urine - Google Patents

Isolation of peptides from urine

Info

Publication number
GB2003887A
GB2003887A GB7835703A GB7835703A GB2003887A GB 2003887 A GB2003887 A GB 2003887A GB 7835703 A GB7835703 A GB 7835703A GB 7835703 A GB7835703 A GB 7835703A GB 2003887 A GB2003887 A GB 2003887A
Authority
GB
United Kingdom
Prior art keywords
peptide
urine
isolation
treated
subjected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB7835703A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nyegaard and Co AS
Original Assignee
Nyegaard and Co AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard and Co AS filed Critical Nyegaard and Co AS
Priority to GB7835703A priority Critical patent/GB2003887A/en
Publication of GB2003887A publication Critical patent/GB2003887A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method of isolation of a physiologically active peptide in which urine from a human or animal subject exhibiting a particular abnormal physiological condition with which said active peptide is associated is treated with a precipitating agent for proteins at a pH in the range 3.5 to 5.0 and the precipitate so formed, after separation from the urine, is dissolved in an aqueous medium and subjected to gel chromatography, fractions containing the desired peptide then being treated to liberate the peptide and subjected to further fractionation to yield fractions containing the liberated peptide.
GB7835703A 1977-09-06 1978-09-05 Isolation of peptides from urine Withdrawn GB2003887A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB7835703A GB2003887A (en) 1977-09-06 1978-09-05 Isolation of peptides from urine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3719277 1977-09-06
GB7835703A GB2003887A (en) 1977-09-06 1978-09-05 Isolation of peptides from urine

Publications (1)

Publication Number Publication Date
GB2003887A true GB2003887A (en) 1979-03-21

Family

ID=26263367

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7835703A Withdrawn GB2003887A (en) 1977-09-06 1978-09-05 Isolation of peptides from urine

Country Status (1)

Country Link
GB (1) GB2003887A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069232A3 (en) * 1981-07-02 1984-07-04 Stanislaw R. Burzynski Purified antineoplaston fractions and methods of treating neoplastic disease
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
EP0156063A3 (en) * 1983-10-19 1987-04-15 Reichelt, Karl Ludvig Hypoglycaemic tetrapeptides
DE3633797A1 (en) * 1986-10-03 1988-04-07 Forssmann Wolf Georg Process for obtaining biologically active proteins (peptides) from human and animal blood (or other body fluids)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069232A3 (en) * 1981-07-02 1984-07-04 Stanislaw R. Burzynski Purified antineoplaston fractions and methods of treating neoplastic disease
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
EP0156063A3 (en) * 1983-10-19 1987-04-15 Reichelt, Karl Ludvig Hypoglycaemic tetrapeptides
DE3633797A1 (en) * 1986-10-03 1988-04-07 Forssmann Wolf Georg Process for obtaining biologically active proteins (peptides) from human and animal blood (or other body fluids)

Similar Documents

Publication Publication Date Title
Duthie et al. A polypeptide responsible for some of the phenomena of acute inflammation
EP0526544A4 (en) Therapeutic uses of actin-binding compounds
NL7800767A (en) ADDITIONAL CONNECTION OF DIPEPTIDE DERIVATIVE AND AMINO ACID DERIVATIVE AS WELL AS THE PROCEDURE FOR PREPARING THIS.
PT87394A (en) PROCESS FOR PLANT TISSUE TRANSFORMATION
EP0089666A3 (en) Human growth hormone variants
DE69033600D1 (en) Process for the isolation of Haemopnilus influenzae Protein-E
ATE59402T1 (en) PROCESS FOR THE SEPARATION OF CHOLESTEROL FROM FAT SUBSTANCES OF ANIMAL ORIGIN AND LOW CHOLESTEROL FAT SUBSTANCES.
ZA889033B (en) Vectors and compounds for direct expression of activated human protein c.
ES2110414T3 (en) SUGAR DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND THEIR PREPARATION.
CA1267497C (en) Protein recovery
NL7800027A (en) PROCESS FOR THE PREPARATION OF POLYAMIDE-FIXED BIOLOGICAL ACTIVE PROTEIN.
SE7902742L (en) DISUBSTITUTED 3-CEFEM-4-CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR THE PREPARATION
AU5121579A (en) Isolation of tissue protein ppg.
SE8703064D0 (en) METHOD FOR ISOLATING ACTIVE ENZYME PREPARATIONS FROM ANIMAL TISSUES
DE3378414D1 (en) Protein (pp13), process for concentrating and obtaining it, and its use
GB2003887A (en) Isolation of peptides from urine
NO173336C (en) Process for Isolating Basement Membrane Proteins from Human or Animal Tissue and Using the Protein Obtained
DE3067643D1 (en) Protein pp 11, process for its isolation and its use
YU176089A (en) PROCEDURE FOR PREPARATION OF BPC SUBSTANCE AND BPC SUBSTANCE
BG100921A (en) ANIMAL AND METHOD FOR TREATMENT OF AUTOMMUNE DISEASES
DE59607417D1 (en) CONJUGATE FOR TREATING INFLAMMATORY DISEASES
SE8600987L (en) PROCEDURE FOR PREPARING A PROTEIN CONCENTRATE FROM WHOLE BLOOD
FI881124A7 (en) Method for extracting protein PP4 from tissues and use of citric acid for this purpose.
AU5476598A (en) Method of obtaining haemin from slaughter blood
ES492470A0 (en) PROCEDURE FOR OBTAINING AN AMINO ACID AND PEPTIDE SOLUTION OF ANIMAL ORIGIN BY ENZYMATIC PROCESS

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)